Startups

Boston Scientific logo

Boston Scientific

Marlborough, Massachusetts, United States

bostonscientific.cominvestors.bostonscientific.com

Boston Scientific Corporation is a global medical-technology manufacturer founded in 1979 and listed on the New York Stock Exchange as BSX. Headquartered in Marlborough, Massachusetts, it develops devices and therapies for cardiovascular, neurological, urological, digestive, respiratory and oncological diseases. Its neuroscience businesses include Vercise deep brain stimulation, WaveWriter spinal cord stimulation and other interventional pain and peripheral-nerve therapies. Device regulatory clearances and approvals are product- and indication-specific; its corporate pipeline is not universally approved. Its corporate venture investment activity is branded Boston Scientific Ventures and backs innovative medical solutions from research through commercialization worldwide. The company’s own site reports more than USD1 billion cumulatively invested in over 70 companies since 2012 and over 40 active holdings; this is deployment across a corporate portfolio, not a single externally raised venture fund. Boston Scientific frequently acquires former venture holdings. Direct issuer financing identifies the corporation as Enspire DBS Therapy’s USD2.5 million strategic investor, disclosed in January 2017; the exact investment closing date is unknown. The retained corporate Company identity and older management affiliations are preserved, while balance-sheet debt issuance is distinguished from venture investing and acquisition consideration.

Founded 1979

Team

Arthur C. ButcherArthur C. ButcherExecutive Vice President and Group President, MedSurg and Asia Pacific
Cathy R. SmithCathy R. SmithBoard Director
Charlie AttlanCharlie AttlanSenior Vice President, Strategy and Business Development
Cheryl PegusCheryl PegusBoard Director
Christophe WeberChristophe WeberBoard Director
David HabigerDavid HabigerBoard Director
David S. WichmannDavid S. WichmannBoard Director
Edward J. LudwigEdward J. LudwigBoard Director
Ellen M. ZaneEllen M. ZaneBoard Director
Jessica L. MegaJessica L. MegaBoard Director
Jim CassidyJim CassidySVP / President, Neuromodulation
Jodi EddyJodi EddySenior Vice President, Enterprise Services and Digital Officer
Jonathan R. MonsonJonathan R. MonsonExecutive Vice President and Chief Financial Officer
Joseph M. FitzgeraldJoseph M. FitzgeraldExecutive Vice President and Group President, Cardiovascular
Kenneth SteinKenneth SteinSenior Vice President, Global Chief Medical Officer
Michael F. MahoneyMichael F. MahoneyChairman and Chief Executive Officer
Miriam O'SullivanMiriam O'SullivanSenior Vice President, Chief Human Resources Officer
Paudie O'ConnorPaudie O'ConnorExecutive Vice President, Global Operations
Rosaleen BurkeRosaleen BurkeSenior Vice President, Global Quality & Regulatory
Stephen MorseStephen MorseSenior Vice President and President, Asia Pacific
Susan E. MoranoSusan E. MoranoBoard Director
Vance R. BrownVance R. BrownExecutive Vice President, General Counsel and Corporate Secretary
Xavier BertrandXavier BertrandSenior Vice President and President, EMEA

Investments

$1.55B2025-02-26Boston Scientific0 participations
$—2024-02-27Boston Scientific0 participations
$—2022-03-08Boston Scientific0 participations
$1B2020-05-27Boston Scientific0 participations
$1B2020-05-27Boston Scientific0 participations
$1.7B2020-05-18Boston Scientific0 participations
$—2019-11-12Boston Scientific0 participations
$4.3B2019-02-25Boston Scientific0 participations
$1B2018-02-26Boston Scientific0 participations
$1.85B2015-05-12Boston Scientific0 participations